FIFTH LANE CAPITAL, LP
Long book
$82.3M
Q1 2026
Positions
58
Top-10 weight
68%
concentration
Last quarter
+16.2%
SPY +14.8%
Turnover
79%
of book per quarter
Strategy in plain words
auto-generated from filingsFIFTH LANE CAPITAL, LP is a diversified fundamental manager, specialised in financials (60% of the long book), running a $82.3M US long book across 58 positions.
The portfolio is concentrated: the top 10 names carry 68% of the portfolio. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: RENATUS TACTICAL ACQUISITI-A, ONESTREAM INC, CANTOR EQUITY PARTNERS-CL A, HOLOGIC INC, CANTOR EQUITY PARTNERS-CL A.
Over the last 9 quarters its long book ran on average 1pp per quarter behind the S&P 500, beating the index in 3 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-3.1%
Q2 2024
+4.4%
Q3 2024
+0.6%
Q4 2024
-7.0%
Q1 2025
+20.9%
Q2 2025
+7.1%
Q3 2025
-3.2%
Q4 2025
-4.3%
Q1 2026
+16.2%
Sector allocation
Financials 45%
Other 33%
Technology 14%
Healthcare 4%
Industrials 3%
Communications 1%
Utilities 0%
Long book by quarter
What does FIFTH LANE own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| RTAC RENATUS TACTICAL ACQUISITI-A | Financials | 1.1M | $11.2M | 13.6% | +47.8% |
| K4F ONESTREAM INC | — | 322.6K | $7.7M | 9.4% | New |
| CEPV CANTOR EQUITY PARTNERS-CL A | Financials | 753.5K | $7.6M | 9.3% | New |
| HO1 HOLOGIC INC | — | 94.5K | $7.1M | 8.7% | +190.9% |
| EA ELECTRONIC ARTS INC | Technology | 17.5K | $3.6M | 4.3% | New |
| ACLXGBX ARCELLX INC | — | 31.0K | $3.6M | 4.3% | New |
| FCRS FUTURECREST ACQUISITION-CL A | Financials | 278.7K | $2.8M | 3.4% | +14.8% |
| NWAX NEW AMERICA ACQUISITION-CL A | Financials | 200.0K | $2.0M | 2.4% | New |
| UNH UNITEDHEALTH GROUP INC | Financials | 7.0K | $1.9M | 2.3% | +22.8% |
| CORZ CORE SCIENTIFIC INC | Financials | 99.8K | $1.5M | 1.8% | +132.0% |
| NVDA NVIDIA CORP | Technology | 7.5K | $1.3M | 1.6% | +36.4% |
| VISN VISTANCE NETWORKS INC | Technology | 64.6K | $1.2M | 1.4% | +545.5% |
| NKTR NEKTAR THERAPEUTICS | Healthcare | 12.0K | $863K | 1.0% | New |
| AMD ADVANCED MICRO DEVICES | Technology | 4.0K | $814K | 1.0% | +33.3% |
| ORCL ORACLE CORP | Technology | 5.0K | $736K | 0.9% | -16.7% |
| TDAY USA TODAY CO INC | Other | 81.1K | $572K | 0.7% | New |
| TSLA TESLA INC | Industrials | 1.5K | $558K | 0.7% | -42.3% |
| RNA ATRIUM THERAPEUTICS INC | Healthcare | 36.0K | $481K | 0.6% | New |
| AAL AMERICAN AIRLINES GROUP INC | Industrials | 40.0K | $430K | 0.5% | New |
| 430 TERNS PHARMACEUTICALS INC | — | 8.0K | $422K | 0.5% | New |
| PLTR PALANTIR TECHNOLOGIES INC-A | Technology | 2.5K | $366K | 0.4% | Held |
| CRWV COREWEAVE INC-CL A | Technology | 4.5K | $349K | 0.4% | -40.0% |
| ASTS AST SPACEMOBILE INC | Communications | 4.0K | $331K | 0.4% | New |
| INTC INTEL CORP | Technology | 7.5K | $331K | 0.4% | New |
| RLMD RELMADA THERAPEUTICS INC | Healthcare | 45.0K | $313K | 0.4% | New |
| APLSUSD APELLIS PHARMACEUTICALS INC | — | 7.5K | $302K | 0.4% | New |
| PPL PPL CORPORATION | Utilities | 5.8K | $298K | 0.4% | New |
| BE BLOOM ENERGY CORP- A | Industrials | 2.0K | $271K | 0.3% | -50.0% |
| AVR ANTERIS TECHNOLOGIES GLOBAL | Healthcare | 47.5K | $264K | 0.3% | New |
| CRNX CRINETICS PHARMACEUTICALS IN | Healthcare | 7.2K | $260K | 0.3% | New |
| RKLB ROCKET LAB CORP | Industrials | 3.5K | $225K | 0.3% | New |
| SABS SAB BIOTHERAPEUTICS INC | Healthcare | 46.5K | $178K | 0.2% | +210.0% |
| RPID RAPID MICRO BIOSYSTEMS INC-A | Healthcare | 71.0K | $161K | 0.2% | +301.1% |
| RKT ROCKET COS INC-CLASS A | Financials | 10.0K | $143K | 0.2% | New |
| CNTB CONNECT BIOPHARMA HOLDINGS L | Healthcare | 45.0K | $118K | 0.1% | New |
| GT GOODYEAR TIRE & RUBBER CO | Other | 10.0K | $66K | 0.1% | New |
| COUR COURSERA INC | Technology | 10.0K | $58K | 0.1% | New |
| BUR BURFORD CAPITAL LTD | Financials | 10.0K | $45K | 0.1% | -84.5% |
| IKT INHIBIKASE THERAPEUTICS INC | Healthcare | 24.9K | $42K | 0.1% | New |
| CVU CPI AEROSTRUCTURES INC | Industrials | 10.6K | $41K | 0.1% | New |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 58 | $82.3M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 13, 2026 | 118 | $131.9M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 12, 2025 | 105 | $99.5M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 13, 2025 | 67 | $82.6M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 13, 2025 | 34 | $23.0M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 40 | $34.0M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 12, 2024 | 51 | $39.6M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 112 | $69.0M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 2, 2024 | 145 | $115.8M | canonical | SEC ↗ |